Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
VYNE Therapeutics Inc. (NASDAQ: VYNE)
VYNE Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-11%
Analyst Rating:
HOLD
Analyst Forecast (1yr):
NOT AVAILABLE
VYNE Stock Analysis
VYNE
PE Ratio:
VYNE
PEG Ratio:
Not Available
VYNE
Forward EPS Growth (12 month):
0.00%
VYNE
PS Ratio:
24.5
VYNE
PSG Ratio:
Not Available
VYNE
Forward Revenue Growth (12 month):
0.00%
VYNE Articles
No data was found